Plan B Decision Mobilizes House Members To Seek FDA Integrity Review
This article was originally published in The Pink Sheet Daily
Executive Summary
A bill directing the agency to conduct a formal review of its decision-making process in turning down the Rx-to-OTC switch application for the emergency contraceptive is slated to be introduced May 13 by Rep. Maloney.